Five years ago, the phrase “health tech” mostly meant one thing: a video call with a doctor while the country or most countries were in lockdown. Telemedicine was the emergency exit. Today, it’s just one door in a much bigger building. India’s digital health ecosystem has moved from crisis improvisation to structural transformation — a shift visible in everything from national health ID adoption to where venture capital is now willing to place its bets.

The companies — Mindbowser, Innovaccer, HealthPlix, Practo, Qure.ai and Napier Healthcare — are not outliers. They are early representatives of a sector that has quietly matured into one of India’s largest and most consequential technology plays. Here’s the fuller picture of what that maturation looks like, where the money and the opportunity are actually flowing, and what still stands in the way.

The pandemic didn’t create health tech — it fast-forwarded it by a decade

Before COVID-19, digital health adoption in India was inching forward. The pandemic compressed years of hesitant behaviour change into a matter of months. Teleconsultations under the government’s eSanjeevani platform crossed 1.2 million by the end of 2021 alone — a volume that would have been unthinkable pre-pandemic — as lockdowns and infection fears pushed both patients and regulators toward remote care almost overnight.

What’s notable is that the growth curve never really flattened after the emergency passed. India’s digital health market was estimated at roughly $8.8–14.5 billion in 2024, depending on the research house doing the counting, with most forecasts putting the compound annual growth rate somewhere between 17% and 25% through the early 2030s — among the fastest expansion rates of any major digital health market globally. Tele-healthcare remains the single largest technology segment, but the composition of the market underneath it has changed considerably.

ABHA: the quiet backbone nobody talks about enough

If there’s one number that captures how far India’s digital health infrastructure has come, it’s this: the Ayushman Bharat Digital Mission (ABDM) crossed 900 million Ayushman Bharat Health Account (ABHA) registrations in 2026, up from just 147 million in 2021. More than 105 crore digital health records are now linked to the system. Uttar Pradesh alone accounts for over 15 crore of those accounts.

ABHA is essentially India’s attempt at a UPI-equivalent for healthcare — a portable, consent-based digital health ID that lets a patient’s records follow them across hospitals, labs and pharmacies instead of living in a folder of loose printouts. It’s the plumbing that makes everything else in this article possible: without a shared identity layer, interoperability platforms like Innovaccer’s Data Activation Platform or EHR-integration specialists like Mindbowser would be solving a much narrower problem. This is also why “interoperability” — unglamorous as it sounds — has become one of the more durable investment themes in Indian health tech rather than a footnote.

From “generic telemedicine” to deep-tech: what investors are actually funding now

Indian health tech has been through a real correction, and it’s worth being honest about that rather than only celebrating the highlight reel. Funding fell sharply after its 2021 peak of roughly $2.83 billion, dropping 55% in 2022 to about $1.4 billion, and 2026 opened with a noticeably slower start than the year before. That’s the unglamorous part of the story.

But the more interesting shift isn’t how much capital is flowing — it’s where. According to Bain & Company estimates cited in recent industry coverage, roughly 30% of healthtech venture funding is now going into MedTech and diagnostics rather than pure-play telemedicine, a category that raised billions in 2020–21 and has since cooled considerably. Investors reviewing programmes like IIT Bombay’s ATMAN accelerator are explicitly looking for defensible IP, a clear CDSCO or FDA regulatory pathway, and measurable clinical outcomes — not another video-consultation app. In the first half of 2026 alone, Indian healthtech startups raised close to $310 million across AI, oncology, genomics, healthcare fintech, rehabilitation and neurotechnology, according to Digital Health News’ funding recap — a sign that capital hasn’t left the sector, it’s just gotten far more selective about clinical seriousness.

This is precisely the “data-to-action” gap our original list was built around. The startups now attracting serious capital are the ones proving they can turn data into a specific, measurable clinical or operational outcome — not just collect more of it.

Four frontiers where the real opportunity is opening up

1. AI-powered diagnostics and clinical decision support. This is arguably the sharpest growth curve in the entire sector. Global market estimates vary widely by research house — from roughly $2 billion to over $10 billion for 2026 depending on scope and methodology — but nearly every analyst agrees on direction: compound annual growth rates in the 20–45% range through the early 2030s, driven by radiologist shortages, rising imaging volumes and the need for earlier disease detection. Qure.ai’s chest X-ray screening tool, now deployed across 4,500+ sites in over 100 countries, is a useful case study: a real-world rollout in Mumbai hospitals reportedly drove a 29% increase in incidental tuberculosis case detection — a concrete example of AI closing a data-to-action gap that costs lives when left open. Newer entrants like Niramai, working on radiation-free AI breast cancer screening, are following a similar playbook into new geographies including Africa, Southeast Asia and the Middle East.

2. Interoperability and data-activation platforms. As ABHA scales, the bottleneck shifts from “does the data exist” to “can systems actually talk to each other.” This is squarely Innovaccer and Mindbowser’s territory, and it’s a category likely to keep growing precisely because ABDM’s Healthcare Professionals Registry, Health Facility Registry and Unified Health Interface are pushing every hospital and clinic toward standardised, shareable records whether they’re ready or not.

3. Chronic disease and remote patient monitoring. With diabetes already the largest single application segment in India’s digital health market, and cardiovascular and other chronic conditions rising steadily, tools that manage patients between hospital visits — not just during them — represent a large and still under-served opportunity. This is also where consumer wearables and hospital-grade remote monitoring are increasingly converging.

4. Healthcare fintech and insurance-tech. The pandemic pushed some insurers to introduce home-based telehealth coverage for the first time, and IRDAI’s inclusion of robotic surgeries signals a slowly evolving reimbursement landscape. But large gaps remain — outpatient consultations, wearables and everyday digital health tools are still largely outside standard insurance coverage in India, which is exactly the kind of structural gap that tends to produce a wave of new startups once regulation catches up.

The headwinds nobody should gloss over

None of this is a straight line upward, and the sector’s own data makes that clear.

• The digital divide is still real. Government data has put basic digital-skills proficiency among Indians above age 15 at roughly 20% — a serious constraint on how far consumer-facing digital health tools can reach without deliberate design for low-literacy, low-connectivity users.
• Regulatory timelines are long. CDSCO approval for medical devices typically runs 18–24 months, which filters out founders looking for quick consumer traction and rewards those building for genuine clinical validation.
• Reimbursement hasn’t caught up with adoption. Wearables, health apps and many telemedicine consultations still sit outside standard insurance coverage in India, which limits how much of this innovation actually reaches cost-sensitive patients versus premium urban segments.
• Consolidation, not just growth, defines 2026. Industry trackers note a shift toward mergers and acquisitions over fresh funding rounds, particularly in chronic care, diagnostics and wellness — a sign the sector is entering a more disciplined, outcomes-first phase rather than a pure land-grab.

Where this leaves the data-to-action thesis

The companies profiled in the original list — spanning custom digital health engineering (Mindbowser), enterprise data platforms (Innovaccer), physician-facing EMRs (HealthPlix), consumer health marketplaces (Practo), diagnostic imaging AI (Qure.ai) and hospital information systems (Napier Healthcare) — each represent a different layer of the same underlying stack. What the post-pandemic data adds is scale and specificity: nearly a billion digital health identities, tens of billions of dollars in market growth, and a venture ecosystem that has stopped rewarding novelty for its own sake and started demanding proof that data actually changes what happens to a patient next.

That’s the real story of health tech five years after the pandemic. The emergency built the audience. What’s being built now — often unglamorously, in the space between EHR systems and insurance claims and radiology queues — is the infrastructure layer that will determine whether Indian healthcare’s digital transformation outlasts the crisis that triggered it.

---

Sources:

1. Grand View Research — India Digital Health Market Report
2. Fortune Business Insights — Digital Health Market
3. Custom Market Insights — India Digital Health Market
4. 6Wresearch — Digital Healthcare Market Size in India
5. OpenGov Asia — ABDM surpasses 900 million ABHA accounts
6. Big News Network — ABDM crosses 90 crore ABHA accounts
7. Organiser — From ABHA to AI
8. Digital Health News — 90 crore ABHA milestone
9. Tracxn — HealthTech in India: 2026 Market & Investment Trends
10. Inc42 — Top 30 Healthtech Startups in India by Funding
11. Medical Buyer — India’s HealthTech sector raises $9.9 billion in 2025
12. Digital Health News — H1 2026 HealthTech Funding Recap
13. GrowthJockey — Top 20 Healthcare Startups in India (2026 Deep Dive)
14. Healthbuzz — Top 10 HealthTech Startups Reshaping Indian Healthcare in 2026
15. EntrepreneurLoop — Indian Health-Tech Funding 2026 (IIT Bombay ATMAN 3.0)
16. Fortune Business Insights — AI in Medical Diagnostics Market
17. Fortune Business Insights — AI in Healthcare Market
18. Business Standard — Indian healthtech funding plunges 55% in 2022